Manning Paul B

EVP & General Manager, PBM at PERRIGO CO · on record since Jun 22, 2010
Director at Candel Therapeutics, Inc. · on record since Apr 2, 2026
Director at Liquidia Corp · on record since Jun 8, 2026
Director at AveXis, Inc. · on record since Feb 12, 2016
10% owner at AveXis, Inc. · on record since Feb 12, 2016
Director at Dova Pharmaceuticals Inc. · on record since Jun 28, 2017
10% owner at Dova Pharmaceuticals Inc. · on record since Jun 28, 2017
Director at Verrica Pharmaceuticals Inc. · on record since Jun 19, 2018
10% owner at Verrica Pharmaceuticals Inc. · on record since Jun 19, 2018
Director at Taysha Gene Therapies, Inc. · on record since Sep 30, 2020
10% owner at Taysha Gene Therapies, Inc. · on record since Sep 30, 2020
10% owner at Liquidia Corp · on record since Nov 19, 2020
10% owner at Acumen Pharmaceuticals, Inc. · on record since Jun 30, 2021
10% owner at Candel Therapeutics, Inc. · on record since Aug 4, 2021
10% owner at Pasithea Therapeutics Corp. · on record since Feb 14, 2023

Insider trading activity of Manning Paul B

Transactions on record: 175; since Feb 12, 2016

Open-market buys: 78; $110.1M

Open-market sells: 10; $41.7M

Companies traded: 7; last filing Oct 2, 2026

Figures computed from official regulatory filings — .

Companies where Manning Paul B has traded

Candel Therapeutics, Inc.23 tx · $29M · Oct 2, 2026
24 tx · $43.9M · Jun 18, 2026
54 tx · $38M · Nov 25, 2025
23 tx · $25.1M · Jun 3, 2025
6 tx · $5M · Jul 8, 2021
21 tx · $416.4M · Nov 12, 2019
24 tx · $10M · May 15, 2018

Track record of Manning Paul B

Statistical track record

Free account

Open-market buys: 84

Last buy: Feb 23, 2026

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of Manning Paul B

Co-insiders of Manning Paul B

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Candel Therapeutics, Inc.Listing on record	Oct 2, 2026	AwardD (derivative)	2,189	8.68 USD	$19K		SEC
Candel Therapeutics, Inc.Listing on record	Jul 1, 2026	AwardD (derivative)	2,199	8.64 USD	$19K		SEC
Candel Therapeutics, Inc.Listing on record	Jun 24, 2026	AwardD (derivative)	32,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Liquidia CorpListing unverified	Jun 18, 2026	Award	5,882	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Liquidia CorpListing unverified	Jun 8, 2026	Sell	-68,265	63.83 USD	$4.4M		SEC
Liquidia CorpListing unverified	Jun 8, 2026	Sell	-11,513	63.13 USD	$726.8K		SEC
Liquidia CorpListing unverified	Jun 8, 2026	Sell	-12,610	64.42 USD	$812.3K		SEC
Liquidia CorpListing unverified	Jun 8, 2026	Sell	-88,487	64.28 USD	$5.7M		SEC
Liquidia CorpListing unverified	Jun 8, 2026	Sell	-19,125	62.62 USD	$1.2M		SEC
Candel Therapeutics, Inc.Listing on record	Apr 2, 2026	AwardD (derivative)	4,618	4.11 USD	$19K		SEC
Candel Therapeutics, Inc.Listing on record	Feb 26, 2026	Buy	550,458	5.45 USD	$3M	conv 25	SEC
Liquidia CorpListing unverified	Feb 12, 2026	Other	-55,116	42.63 USD	$2.3M		SEC
Liquidia CorpListing unverified	Feb 12, 2026	Other	55,116	42.63 USD	$2.3M		SEC
Verrica Pharmaceuticals Inc.Listing on record	Nov 25, 2025	Buy	2,750,762	4.24 USD	$11.7M	conv 81ClusterUnusual size	SEC
Verrica Pharmaceuticals Inc.Listing on record	Nov 25, 2025	BuyD (derivative)	687,690	—	n/a (No price was disclosed in the filing)	Cluster	SEC
Verrica Pharmaceuticals Inc.Listing on record	Nov 25, 2025	Buy	1,375,380	4.24 USD	$5.8M	conv 62Cluster	SEC
Verrica Pharmaceuticals Inc.Listing on record	Nov 25, 2025	BuyD (derivative)	343,845	—	n/a (No price was disclosed in the filing)	Cluster	SEC
Liquidia CorpListing unverified	Sep 2, 2025	Sell	-74,230	29.14 USD	$2.2M		SEC
Liquidia CorpListing unverified	Sep 2, 2025	Sell	-154,337	27.94 USD	$4.3M		SEC
Liquidia CorpListing unverified	Sep 2, 2025	Sell	-254,038	28.67 USD	$7.3M		SEC
Liquidia CorpListing unverified	Sep 2, 2025	Sell	-188,232	27.62 USD	$5.2M		SEC
Candel Therapeutics, Inc.Listing on record	Jun 26, 2025	Award	1,070,663	4.67 USD	$5M		SEC
Liquidia CorpListing unverified	Jun 20, 2025	Award	18,396	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Candel Therapeutics, Inc.Listing on record	Jun 18, 2025	AwardD (derivative)	14,240	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Taysha Gene Therapies, Inc.Listing on record	Jun 3, 2025	Buy	750,000	2.75 USD	$2.1M	conv 33	SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Candel Therapeutics, Inc.Listing on record	Oct 2, 2026	AwardD (derivative)	2,189	8.68 USD	$19K		SEC
Candel Therapeutics, Inc.Listing on record	Jul 1, 2026	AwardD (derivative)	2,199	8.64 USD	$19K		SEC
Candel Therapeutics, Inc.Listing on record	Jun 24, 2026	AwardD (derivative)	32,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Liquidia CorpListing unverified	Jun 18, 2026	Award	5,882	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Liquidia CorpListing unverified	Jun 8, 2026	Sell	-68,265	63.83 USD	$4.4M		SEC
Liquidia CorpListing unverified	Jun 8, 2026	Sell	-11,513	63.13 USD	$726.8K		SEC
Liquidia CorpListing unverified	Jun 8, 2026	Sell	-12,610	64.42 USD	$812.3K		SEC
Liquidia CorpListing unverified	Jun 8, 2026	Sell	-88,487	64.28 USD	$5.7M		SEC
Liquidia CorpListing unverified	Jun 8, 2026	Sell	-19,125	62.62 USD	$1.2M		SEC
Candel Therapeutics, Inc.Listing on record	Apr 2, 2026	AwardD (derivative)	4,618	4.11 USD	$19K		SEC
Candel Therapeutics, Inc.Listing on record	Feb 26, 2026	Buy	550,458	5.45 USD	$3M	conv 25	SEC
Liquidia CorpListing unverified	Feb 12, 2026	Other	-55,116	42.63 USD	$2.3M		SEC
Liquidia CorpListing unverified	Feb 12, 2026	Other	55,116	42.63 USD	$2.3M		SEC
Verrica Pharmaceuticals Inc.Listing on record	Nov 25, 2025	Buy	2,750,762	4.24 USD	$11.7M	conv 81ClusterUnusual size	SEC
Verrica Pharmaceuticals Inc.Listing on record	Nov 25, 2025	BuyD (derivative)	687,690	—	n/a (No price was disclosed in the filing)	Cluster	SEC
Verrica Pharmaceuticals Inc.Listing on record	Nov 25, 2025	Buy	1,375,380	4.24 USD	$5.8M	conv 62Cluster	SEC
Verrica Pharmaceuticals Inc.Listing on record	Nov 25, 2025	BuyD (derivative)	343,845	—	n/a (No price was disclosed in the filing)	Cluster	SEC
Liquidia CorpListing unverified	Sep 2, 2025	Sell	-74,230	29.14 USD	$2.2M		SEC
Liquidia CorpListing unverified	Sep 2, 2025	Sell	-154,337	27.94 USD	$4.3M		SEC
Liquidia CorpListing unverified	Sep 2, 2025	Sell	-254,038	28.67 USD	$7.3M		SEC
Liquidia CorpListing unverified	Sep 2, 2025	Sell	-188,232	27.62 USD	$5.2M		SEC
Candel Therapeutics, Inc.Listing on record	Jun 26, 2025	Award	1,070,663	4.67 USD	$5M		SEC
Liquidia CorpListing unverified	Jun 20, 2025	Award	18,396	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Candel Therapeutics, Inc.Listing on record	Jun 18, 2025	AwardD (derivative)	14,240	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Taysha Gene Therapies, Inc.Listing on record	Jun 3, 2025	Buy	750,000	2.75 USD	$2.1M	conv 33	SEC